Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO 130948 (25 August 2022)
[New search]
[Printable PDF version]
[Help]
Medicines and Healthcare Products Regulatory Agency
The complainant requested information from the Medicines & Healthcare products Regulatory Agency (“MHRA”) held by staff working on the licensing of and/or pharmacovigilance for COVID-19 vaccines about suspected adverse cardiac reactions. MHRA refused the request as it considered that compliance with it would exceed the cost limit under section 12(1) FOIA.The Commissioner’s decision is that MHRA has correctly cited section 12(1) FOIA, in response to the request. He also finds that it has complied with its obligations under section 16(1) FOIA to provide adequate advice and assistance to the complainant. The Commissioner does not require the public authority to take any further steps to ensure compliance with the legislation.
FOI 12(1):
Complaint not upheld
FOI 16:
Complaint not upheld
Decision notice: 130948
BAILII:
Copyright Policy |
Disclaimers |
Privacy Policy |
Feedback |
Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKICO/2022/130948.html
